Royal Bank of Canada’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,000
| Closed | -$16K | – | 6445 |
|
|
2024
Q4 | $16K | Buy |
+4,000
| New | +$16K | ﹤0.01% | 5699 |
|
|
2024
Q2 | – | Sell |
-121
| Closed | -$3K | – | 6691 |
|
|
2024
Q1 | $3K | Sell |
121
-1,464
| -92% | -$36.3K | ﹤0.01% | 6129 |
|
|
2023
Q4 | $30K | Buy |
1,585
+783
| +98% | +$14.8K | ﹤0.01% | 5642 |
|
|
2023
Q3 | $14K | Buy |
802
+303
| +61% | +$5.29K | ﹤0.01% | 5809 |
|
|
2023
Q2 | $15K | Buy |
+499
| New | +$15K | ﹤0.01% | 5867 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | – | – | 6800 |
|
|
2022
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6986 |
|
|
2022
Q2 | – | Sell |
-304
| Closed | -$14K | – | 6920 |
|
|
2022
Q1 | $14K | Sell |
304
-627
| -67% | -$28.9K | ﹤0.01% | 6303 |
|
|
2021
Q4 | $36K | Buy |
931
+337
| +57% | +$13K | ﹤0.01% | 6020 |
|
|
2021
Q3 | $30K | Buy |
594
+282
| +90% | +$14.2K | ﹤0.01% | 5945 |
|
|
2021
Q2 | $27K | Buy |
+312
| New | +$27K | ﹤0.01% | 5894 |
|